TEC14-Reproducción Humana y Enfermedades Hereditarias y Complejas

Analysing endometrial microbiome: methodological considerations and recommendations for good practice

HUMAN REPRODUCTION, 2021;

FI:6,918; D1

Assessing the testicular sperm microbiome: a low-biomass site with abundant contamination

REPRODUCTIVE BIOMEDICINE ONLINE, 2021;

FI:3,828; Q1

Cardiorespiratory fitness in children with overweight/obesity: Insights into the molecular mechanisms

SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2021;

FI:4,221; Q1

Assessment of an intervention to optimise antenatal management of women admitted with preterm labour and intact membranes using amniocentesis-based predictive risk models: study protocol for a randomised controlled trial (OPTIM-PTL Study)

BMJ OPEN, 2021;

FI:2,692; Q2

Characteristics of Heart Rate Tracings in Preterm Fetus

MEDICINA-LITHUANIA, 2021;

FI:2,43; Q2

Cross-disorder analysis of endometriosis and its comorbid diseases reveals shared genes and molecular pathways and proposes putative biomarkers of endometriosis

REPRODUCTIVE BIOMEDICINE ONLINE, 2020;

FI:3,218; Q1

Deficiency of the onco-miRNA cluster, miR-106b similar to 25, causes oligozoospermia and the cooperative action of miR-106b similar to 25 and miR-17 similar to 92 is required to maintain male fertility

MOLECULAR HUMAN REPRODUCTION, 2020;

FI:3,636; Q1

DNA methylation in infants with low and high body fatness

BMC GENOMICS, 2020;

FI:3,594; Q2

An integrated model with classification criteria to predict vaginal delivery success after cesarean section

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020;

FI:1,737; Q3

Comparison of MDRD and the old CKD-EPI equations with the new CKD-EPI equations in kidney transplant patients when glomerular filtration rate is measured with 51Cr-EDTA

NEFROLOGIA, 2020;

FI:1,544; Q4

The seminal microbiome in health and disease

NATURE REVIEWS UROLOGY, 2019;

FI:9,333; D1

Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy

PHARMACEUTICS, 2019;

FI:4,773; D1

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

NATURE COMMUNICATIONS, 2019;

FI:11,878; D1

Identification of a 3 ‘-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

ARTHRITIS & RHEUMATOLOGY, 2019;

FI:9,002; D1

Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells

SCIENTIFIC REPORTS, 2019;

FI:4,011; Q1

Can we improve risk communication about non-invasive prenatal testing?

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018;

FI:4,876; D1

Decisions about aneuploidy screening: why women’s reasons are important

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018;

FI:4,876; D1

Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample

PATIENT EDUCATION AND COUNSELING, 2018;

FI:2,785; D1

Living in the past: The impact of victimization memory on threat perceptions

MEMORY STUDIES, 2018;

FI:0,922; D1

Reliability and agreement on embryo assessment: 5 years of an external quality control programme

REPRODUCTIVE BIOMEDICINE ONLINE, 2018;

FI:2,967; Q1

Cassandra’s Regret: The Psychology of Not Wanting to Know

PSYCHOLOGICAL REVIEW, 2017;

FI:7,638; D1

Language and motor skills in siblings of children with autism spectrum disorder: A meta-analytic review

AUTISM RESEARCH, 2017;

FI:3,765; D1

Infants at-risk for autism spectrum disorder: Patterns of vocalizations at 14 months

AUTISM RESEARCH, 2017;

FI:3,765; D1

Designing Visual Aids That Promote Risk Literacy: A Systematic Review of Health Research and Evidence-Based Design Heuristics

HUMAN FACTORS, 2017;

FI:2,219; Q1

Inter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse

PLOS ONE, 2017;

FI:2,806; Q1

Improving risk literacy in surgeons

PATIENT EDUCATION AND COUNSELING, 2016;

FI:2,232; D1

Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHREaEuro

HUMAN REPRODUCTION, 2016;

FI:4,621; D1

Measuring Graph Literacy without a Test: A Brief Subjective Assessment

MEDICAL DECISION MAKING, 2016;

FI:2,908; Q1

Type D personality is related to severity of acute coronary syndrome in patients with recurrent cardiovascular disease

BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2016;

FI:2,895; Q1

Commentary: Risky decision-making is associated with residential choice in healthy older adults

FRONTIERS IN PSYCHOLOGY, 2016;

FI:2,463; Q1

Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program

FERTILITY AND STERILITY, 2015;

FI:4,59; D1

Simple But Powerful Health Messages for Increasing Condom Use in Young Adults

JOURNAL OF SEX RESEARCH, 2015;

FI:2,695; D1

Neural mechanisms underlying urgent and evaluative behaviors: An fMRI study on the interaction of automatic and controlled processes

HUMAN BRAIN MAPPING, 2015;

FI:5,969; D1

Is Patients’ Numeracy Related to Physical and Mental Health?

MEDICAL DECISION MAKING, 2015;

FI:3,24; Q1

The Impact of Depression on Self-Other Discrepancies in Decision Making

JOURNAL OF BEHAVIORAL DECISION MAKING, 2015;

FI:2,069; Q1

Estudio de las causas genéticas de la infertilidad masculina debida a fallo espermatogénico

Financiador: CONSEJERÍA DE TRANSFORMACIÓN ECONÓMICA, INDUSTRIA, CONOCIMIENTO Y UNIVERSIDADES

Número de expediente: PY20_00212

Tiempo de ejecución: 04/10/2021 - 30/06/2023

IP: FRANCISCO DAVID CARMONA LOPEZ

Caracterización molecular de entidades subclínicas de la infertilidad masculina (AZOONÓMICA2)

Financiador: AGENCIA ESTATAL DE INVESTIGACIÓN

Número de expediente: PID2020-120157RB-I00

Tiempo de ejecución: 01/09/2021 - 31/08/2024

IP: ROGELIO PALOMINO MORALES

Bases genéticas y moleculares del fallo espermatogénico severo

Financiador: UNIVERSIDAD DE GRANADA

Número de expediente: CTS-584

Tiempo de ejecución: 01/07/2021 - 30/09/2023

IP: FRANCISCO DAVID CARMONA LOPEZ

Análisis de la Utilidad de la Transferencia Diferida en Un Programa de Fecundación In Vitro Con política de Embrión Único

Financiador: CONSEJERÍA DE SALUD

Número de expediente: PI-0353-2016

Tiempo de ejecución: 01/01/2017 - 31/12/2019

IP: ANA CLAVERO GILABERT

Microbiota uterina en endometriosis: potenciales biomarcadores en enfermedad y del resultado en el tratamiento de infertilidad (MENDO)

Financiador: UNIVERSIDAD DE GRANADA

Número de expediente: B-CTS-500-UGR18

Tiempo de ejecución: 01/01/2020 - 31/12/2021

IP: SIGNE ALTMAE

Optimización del manejo antenatal de mujeres con amenaza de parto pretérmino mediante modelos de predicción: estudio clínico randomizado multicéntrico abierto

Financiador: FUNDACIÓ CLÍNIC PER A LA RECERCA BIOMÈDICA

Tipo de prueba: ENSAYO CLINICO INDEPENDIENTE

Tiempo de ejecución: 16/12/2021 - 30/06/2023

IP: MARIA PAZ CARRILLO BADILLO

Ensayo en Fase III sobre la Eficacia y Seguridad del metilbardoxolona en Pacientes con Enfermedad Poliquística Renal Autosómica Dominante. FALCON

Financiador: REATA PHARMACEUTICALS INC

Tipo de prueba: ENSAYO CLINICO COMERCIAL

Tiempo de ejecución: 02/03/2021 - 30/06/2023

IP: RAFAEL JOSE ESTEBAN DE LA ROSA

Estudio multicentrico, abierto, propectivo, aleatorizado para explorar la morbimortalidad en pacientes dializados con hemodialisis extendida en comparacion con la hemodiafiltracion en linea. Estudio Mother HDx

Financiador: FUNDACION SENEFRO

Tipo de prueba: INV. CLINICA PRODUCTO SANITARIO INDEP.

Tiempo de ejecución: 07/02/2020 - 30/03/2022

IP: MARIA DOLORES PRADOS GARRIDO

Ensayo en fase 2, aleatorizado, doble ciego, controlado con placebo para evaluar la seguridad, eficacia, farmacodinámica y farmacocinética de SAR339375 administrado como inyección subcutánea semanalmente en pacientes con sín

Financiador: GENZYME CORPORATION

Tipo de prueba: ENSAYO CLINICO COMERCIAL

Tiempo de ejecución: 15/10/2020 - 31/08/2023

IP: RAFAEL JOSE ESTEBAN DE LA ROSA

The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT).

Financiador: LILLY, S.A.

Tipo de prueba: ENSAYO CLINICO COMERCIAL

Tiempo de ejecución: 13/07/2020 - 30/10/2024

IP: MARTIN LOPEZ DE LA TORRE CASARES

Estudio posautorizacion de seguridad multicentrico y no intervencionista de 6 años de duracion realizado en pacientes a los que se ha recetado JINARC debido a poliquitosis renal autosomica dominante

Financiador: OTSUKA PHARMACEUTICAL EUROPE LTD

Tipo de prueba: ESTUDIO POSAUTORIZACION COMERCIAL

Tiempo de ejecución: 03/11/2020 - 30/09/2029

IP: ANA ISABEL MORALES GARCIA